TMCnet News
Greiner Bio-One North America, Inc. Announces Contract Renewal with Vizient, Inc.Greiner Bio-One North America, Inc. is proud to announce an extension of the supplier agreement between Greiner Bio-One North America, Inc. and Vizient, Inc., the largest member-driven health care performance improvement company in the country. This new contract continues a long standing and successful relationship between the two organizations for high-quality phlebotomy products now extending through January 31, 2021. The extension of this contract can be directly attributed to Greiner Bio-One's focus on providing innovative, high-quality products, as well as a dedication to world class training, customer and technical service. We are pleased to have the opportunity to continue to offer our services under this contract. "We look forward to a continued relationship with Vizient, Inc., as this aligns with our dedication to impact lives hrough improved patient outcomes," said A.C. Marchionne, President and Chairman of the Board for Greiner Bio-One North America, Inc. About Greiner Bio-One North America, Inc. Greiner Bio-One North America, Inc. is a privately held plastic manufacturing company located in Monroe, NC whose three divisions manufacture a variety of products for the medical and research fields. The manufactured products include plasticware for the cultivation and analysis of cell and tissue cultures, microplates for high-throughput screening related to drug screening, products for blood and specimen collection, tests for the detection of bacteria and viruses, as well as, custom-made products. As an international manufacturer with global reach, Greiner Bio-One provides the manufacturing, distribution logistics and product application support to the world's largest hospitals, pharmaceutical and biotechnology corporations. For more information about Greiner Bio-One North America, Inc. please visit http://www.gbo.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170628005013/en/ |
